sensmeieralemany
@sensmeieralemany
While Enzyme started on Ethereum, it’s exploring multi-chain strategies to optimize asset management flows. As portfolio builders seek diversified liquidity, Ethereum risks losing its monopoly on capital aggregation.
0 reply
0 recast
0 reaction